Synthesis, characterization and antimicrobial activity of arylhydrazones of methylene active compounds

[1]  L. Martins,et al.  Complexes of copper(II) with 3-(ortho-substituted phenylhydrazo)pentane-2,4-diones: syntheses, properties and catalytic activity for cyclohexane oxidation. , 2011, Dalton transactions.

[2]  A. Pombeiro,et al.  Ortho-hydroxyphenylhydrazo-β-diketones: tautomery, coordination ability, and catalytic activity of their copper(II) complexes toward oxidation of cyclohexane and benzylic alcohols. , 2011, Inorganic chemistry.

[3]  A. Pombeiro,et al.  Ion Pairs of 5,5-dimethyl-2-(2-hydroxy-3,5-disulfophenylhydrazo)cyclohexane-1,3-dione with Cationic Surface-Active Substances as Analytical Reagent for Determination of Copper(II) , 2010 .

[4]  N. Siddiqui,et al.  Benzothiazole Incorporated Barbituric Acid Derivatives: Synthesis and Anticonvulsant Screening , 2009, Archiv der Pharmazie.

[5]  V. Nizet,et al.  Skin microbiota: a source of disease or defence? , 2008, The British journal of dermatology.

[6]  Rayees U. H. Mattoo,et al.  Synthesis, Characterization and Antimicrobial Activity of Long-Chain Hydrazones , 2008 .

[7]  David L. Smith,et al.  Hospitalizations and Deaths Caused by Methicillin-Resistant Staphylococcus aureus, United States, 1999–2005 , 2007, Emerging infectious diseases.

[8]  K. Bothara,et al.  Synthesis and anticonvulsant activity of clubbed thiazolidinone–barbituric acid and thiazolidinone–triazole derivatives , 2007 .

[9]  E. Ashry,et al.  Synthesis of antipyrine derivatives derived from dimedone , 2007 .

[10]  Matti Karp,et al.  Whole cell strategies based on lux genes for high throughput applications toward new antimicrobials. , 2006, Combinatorial chemistry & high throughput screening.

[11]  Y. Burgart,et al.  Synthesis, analgesic and antipyretic activity of 2-(antipyrin-4-yl)hydrazones of 1,2,3-triketones and their derivatives , 2006, Pharmaceutical Chemistry Journal.

[12]  L. Kabasakal,et al.  Synthesis of Some Novel Azo Derivatives of 3,5‐Dimethly‐1‐(2‐hydroxyethyl)pyrazole as Potent Analgesic Agents , 2006, Archiv der Pharmazie.

[13]  H. Goossens,et al.  Outpatient antibiotic use in Europe and association with resistance: a cross-national database study , 2005, The Lancet.

[14]  M. Kidwai,et al.  Ecofriendly synthesis of novel antifungal (thio)barbituric acid derivatives , 2005 .

[15]  A. A. Hartmann.  Staphylococci of the normal human skin flora , 1978, Archives of Dermatological Research.

[16]  I. Kukavica-Ibrulj,et al.  In vivo functional genomics of Pseudomonas aeruginosa for high-throughput screening of new virulence factors and antibacterial targets. , 2003, Environmental microbiology.

[17]  L. Galluzzi,et al.  Amplified Detection of Transcriptional and Translational Inhibitors in Bioluminescent Escherichia Coli K-12 , 2003, Journal of biomolecular screening.

[18]  M. Karp,et al.  An Escherichia coli Biosensor Strain for Amplified and High Throughput Detection of Antimicrobial Agents , 2002, Journal of biomolecular screening.

[19]  D. Livermore,et al.  Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa: our worst nightmare? , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[20]  P. Long,et al.  Prospects for Generating New Antibiotics , 2002, Science progress.

[21]  R. K. Saxena,et al.  Novel synthetic approach for antifungal and antibacterial organotin compounds , 2000 .

[22]  Anant B. Patel,et al.  Synthesis, spectroscopic, electrochemical and antibacterial studies of new Ru(II) 1,10-phenanthroline complexes containing aryldiazopentane-2,4-dione as co-ligand , 2000 .

[23]  Ş. Küçükgüzel,et al.  Synthesis and antimycobacterial activity of some coupling products from 4-aminobenzoic acid hydrazones , 1999 .

[24]  A. Zaritsky,et al.  Transcription‐ and translation‐dependent changes in membrane dynamics in bacteria: testing the transertion model for domain formation , 1999, Molecular microbiology.

[25]  K. Rolston,et al.  Staphylococcus epidermidis: emerging resistance and need for alternative agents. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[26]  M. Kist,et al.  Asymmetric Synthesis and Structure‐Activity Relationship of the Four Stereoisomers of the Antibiotic Amidinomycin Part 2: Microbiological Testing , 1997, Archiv der Pharmazie.

[27]  J. Desnottes.  New targets and strategies for the development of antibacterial agents. , 1996, Trends in biotechnology.

[28]  R. Eng,et al.  Bactericidal effects of antibiotics on slowly growing and nongrowing bacteria , 1991, Antimicrobial Agents and Chemotherapy.

[29]  G. Archer.  Antimicrobial Susceptibility and Selection of Resistance Among Staphylococcus epidermidis Isolates Recovered from Patients with Infections of Indwelling Foreign Devices , 1978, Antimicrobial Agents and Chemotherapy.

[30]  J. Sheagren,et al.  In Vitro Activity of Rifampin Alone and in Combination with Nafcillin and Vancomycin Against Pathogenic Strains of Staphylococcus aureus , 1978, Antimicrobial Agents and Chemotherapy.

[31]  H. Yao,et al.  Azo-Hydrazone Conversion. I. The Japp-Klingemann Reaction , 1962 .

[32]  E. Abraham,et al.  An Enzyme from Bacteria able to Destroy Penicillin , 1940, Nature.

[33]  F. R. Japp,et al.  Ueber die Constitution einiger sogenannten gemischten Azoverbindungen , 1888 .